Analytical comparability study of recombinant monoclonal antibody therapeutics

Аналитическое исследование сопоставимости рекомбинантных терапевтических моноклональных антител
Shara M. Dellatore, Alain Beck, Dongdong Wang, Alyssa Neill, Christine Nowak, Gomathinayagam Ponniah, Joanne Sun, Amit Katiyar, Ning Li, Alexandre Ambrogelly, Stephen Gozo, Shara Dellatore, Yune Kune, Ram Bhat, Cory A. King, Bruce D. Mason, Hongcheng Liu
2018-03-07

analytical comparabilitycomparability studiesprocess changesproduct quality attributesrecombinant monoclonal antibodies
Process changes are inevitable in the life cycle of recombinant monoclonal antibody therapeutics. Products made using pre- and post-change processes are required to be comparable as demonstrated by comparability studies to qualify for continuous development and commercial supply. Establishment of comparability is a systematic process of gathering and evaluating data based on scientific understanding and clinical experience of the relationship between product quality attributes and their impact on safety and efficacy. This review summarizes the current understanding of various modifications of recombinant monoclonal antibodies. It further outlines the critical steps in designing and executing successful comparability studies to support process changes at different stages of a product's lifecycle.
1
Comparability is established by systematically evaluating data linking product quality attributes with potential impacts on safety and efficacy.
2
Pre- and post-change products must demonstrate comparability to support continued development and commercial supply.
3
Process changes are inevitable throughout the lifecycle of recombinant monoclonal antibody therapeutics.
4
The review summarizes current knowledge of recombinant monoclonal antibody modifications and outlines critical steps for designing and executing comparability studies across product lifecycle stages.

recombinant monoclonal antibody therapeutics manufactured using pre- and post-change processes

analytical comparability of product quality attributes and their implications for safety and efficacy across process changes

Publication Details
Publication Date
2018-03-07
Journal
Publisher
ISSN
Cited by
102
Access Type
Author Information
Authors
Shara M. Dellatore
Alain Beck
Dongdong Wang
Alyssa Neill
Christine Nowak
Gomathinayagam Ponniah
Joanne Sun
Amit Katiyar
Ning Li
Alexandre Ambrogelly
Stephen Gozo
Shara Dellatore
Yune Kune
Ram Bhat
Cory A. King
Bruce D. Mason
Hongcheng Liu
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%